Involvement of AT1 angiotensin receptors in the vasomodulatory effect of des-aspartate-angiotensin I in the rat renal vasculature
Angiotensin II is known to act primarily on the angiotensin AT1 receptors to mediate its physiological and pathological actions. Des-aspartate-angiotensin I (DAA-I) is a bioactive angiotensin peptide and have been shown to have contrasting vascular actions to angiotensin II. Previous work in this l...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2008
|
| Subjects: | |
| Online Access: | http://eprints.um.edu.my/2448/1/Involvement_of_AT1_angiotensin_receptors_in_the_vasomodulatory_effect_of_des-aspartate-angiotensin_I_in_the_rat_renal_vasculature.pdf http://eprints.um.edu.my/2448/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Angiotensin II is known to act primarily on the angiotensin AT1 receptors to mediate its physiological and pathological actions. Des-aspartate-angiotensin I (DAA-I) is a bioactive
angiotensin peptide and have been shown to have contrasting vascular actions to angiotensin II. Previous work in this laboratory has demonstrated an overwhelming vasodepressor modulation on angiotensin II-induced vasoconstriction by DAA-I. The present study investigated the involvement of the AT1 receptor in the actions of DAA-I on angiotensin IIinduced vascular actions in the renal vasculature of normotensive Wistar–Kyoto rats (WKY), spontaneously hypertensive rats (SHR) and streptozotocin (STZ)-induced diabetic rats. The findings revealed that the angiotensin receptor in rat kidney homogenate was mainly of the AT1 subtype. The AT1 receptor density was significantly higher in the kidney of the SHR. The increase in AT1 receptor density was also confirmed by RT-PCR and Western blot analysis. In contrast, AT1 receptor density was significantly reduced in the kidney of the streptozotocininduced diabetic rat. Perfusion with 10 �9 M DAA-I reduced the AT1 receptor density in the kidneys of WKY and SHR rats suggesting that the previously observed vasodepressor modulation of the nonapeptide could be due to down-regulation or internalization of AT1 receptors. RT-PCR and Western blot analysis showed no significant changes in the content of AT1 receptor mRNA and protein. This supports the suggestion that DAA-I causes internalization of AT1 receptors. In the streptozotocin-induced diabetic rat, no significant changes in renal AT1 receptor density and expression were seen when its kidneys were similarly perfused with DAA-I. |
|---|